Skip to content
healthcare.dev

Bumetanide

NDC 76282-799, Bumetanide, tablet, from Exelan Pharmaceuticals, Inc..

Product NDC
76282-799
Status
Listed
Labeler
Exelan Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212931
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-799 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUMETANIDE2 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
76282-799-0176282079901100 TABLET in 1 BOTTLE (76282-799-01)
76282-799-0576282079905500 TABLET in 1 BOTTLE (76282-799-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/06745425-e7e7-4413-b9ff-22b121f0ea9a
  • NADAC price for package 76282079901

    GET /v1/drugs/nadac/76282079901
  • NADAC price for package 76282079905

    GET /v1/drugs/nadac/76282079905

Use it

Look up 76282-799 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-799 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-799. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.